2552 — Hua Medicine Cashflow Statement
0.000.00%
Last trade - 00:00- HK$3.25bn
- HK$2.34bn
- CNY492.93m
Annual cashflow statement for Hua Medicine, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -326 | -204 | -211 | -250 | 1,106 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 40.3 | -31.3 | -66.6 | -94.4 | -1,233 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -19.2 | -27.1 | 1,131 | -108 | 41.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -273 | -230 | 889 | -418 | -52.1 |
| Capital Expenditures | -66.9 | -27.5 | -9.84 | -3.86 | -7.55 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -1.33 | 22.7 | 17.9 | 13.9 | 6.89 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -68.2 | -4.75 | 8.08 | 10 | -0.654 |
| Financing Cash Flow Items | — | -0.088 | -5.08 | -6.78 | -6.18 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -6.13 | 21.5 | 69.1 | 83.7 | 9.1 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -357 | -185 | 970 | -321 | -47.5 |